Brazil has started diplomatic efforts to get the Oxford-AstraZeneca vaccine from India.
The activities started in Brazil on Monday. The news agency Reuters reported this information.
According to Reuters, Brazil is one of the most affected countries in the world in Corona. The country wants to start corona vaccination activities soon. That is why they are trying to get the Oxford-Astragene vaccine from India. Brazil is contacting the country through diplomatic channels with the aim of avoiding India's export ban on the vaccine.
At the same time, an organization of a private health clinic in Brazil has taken steps to buy India Biotech's 'Covacin' vaccine from India.
The Brazilian Association of Vaccine Clinics (ABCVAC) said it was interested in buying 5 million doses of the vaccine from India Biotech. For this, they are in talks with India Biotech. They have already signed a memorandum of understanding with India Biotech to buy the vaccine.
ABCVAC's final agreement with India Biotech depends on the approval of Brazil's health regulator. If they approve the India Biotech ticker in Brazil, the final deal will be. However, India Biotech has not yet applied to the Brazilian health regulator for permission to use the vaccine.
Bharat Biotech is a Hyderabad-based pharmaceutical company. They have developed a vaccine called covacin in the native method. The covacin vaccine has completed two of the three trial steps. The third or final stage trial of the vaccine is now underway. The trial of the third phase of the vaccine started last November.
Brazil was once cited as an example in the developing world of successful mass vaccination. But it is the Brazilian government's and the private sector's actions that show that the country has lagged behind in getting corona vaccines.
On Sunday, India's drug regulator approved the use of two corona vaccines. The two vaccines are the Oxford-AstraZeneca Covishield, developed by India Biotech's Covacin and Serum Institute.
Adar Punawala, head of the Seram Institute, told Reuters on the day of the approval that he thought the Indian government would ban the export of the corona vaccine.
After the statement of the head of the Serum Institute, Brazil sat motionless.
Brazil's health regulator has already approved the import of 2 million doses of the Oxford-AstraZeneca vaccine from India.
Brazilian diplomats are working to ensure that Oxford-AstraZeneca shipments from India do not fall under the country's export embargo, according to two Brazilian officials familiar with the issue.
The Fiocruz Institute, funded by the Brazilian government involved in vaccine imports, has confirmed that the country's foreign ministry is leading talks with the Indian government.
The Brazilian government is hopeful that it will be able to import the Oxford-Astragene vaccine from India, a Brazilian government official said. In this case, it will be possible to resolve any kind of dispute through diplomatic means.
On 30 December, the United Kingdom approved the use of the first Oxford-AstraZeneca corona vaccine. The application of this ticker has started in the country since yesterday.
The Oxford-AstraZeneca vaccine can be stored in the refrigerator. This tick is to be taken in two doses. The interval between the two doses is four weeks.
0 Comments